EXOSC8 anticorps (AA 2-276) (FITC)

N° du produit ABIN7152291

Détail du produit anti-EXOSC8 anticorps (FITC)

Antigène: EXOSC8 (Exosome Component 8 (EXOSC8))

Épitope: AA 2-276

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp EXOSC8 est conjugé à/à la FITC

Application: Veuillez nous consulter SVP

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Exosome complex component RRP43 protein (2-276AA)

Isotype: IgG

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur EXOSC8

Antigène: EXOSC8 (Exosome Component 8 (EXOSC8))

Autre désignation: EXOSC8 (EXOSC8 Produits)

Synonymes: anticorps wu:fb79a10, anticorps zgc:110381, anticorps MGC52847, anticorps MGC132146, anticorps EXOSC8, anticorps MGC79733, anticorps CIP3, anticorps EAP2, anticorps OIP2, anticorps RP11-421P11.3, anticorps RRP43, anticorps Rrp43p, anticorps bA421P11.3, anticorps p9, anticorps 2310032N20Rik, anticorps mKIAA4013, anticorps exosome component 8, anticorps exosome component 8 S homeolog, anticorps Exosc8, anticorps exosc8, anticorps exosc8.S, anticorps EXOSC8

Sujet:

Background: Non-catalytic component of the RNA exosome complex which has 3\'->5\' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events. In the nucleus, the RNA exosome complex is involved in proper maturation of stable RNA species such as rRNA, snRNA and snoRNA, in the elimination of RNA processing by-products and non-coding \'pervasive\' transcripts, such as antisense RNA species and promoter-upstream transcripts (PROMPTs), and of mRNAs with processing defects, thereby limiting or excluding their export to the cytoplasm. The RNA exosome may be involved in Ig class switch recombination (CSR) and/or Ig variable region somatic hypermutation (SHM) by targeting AICDA deamination activity to transcribed dsDNA substrates. In the cytoplasm, the RNA exosome complex is involved in general mRNA turnover and specifically degrades inherently unstable mRNAs containing AU-rich elements (AREs) within their 3\' untranslated regions, and in RNA surveillance pathways, preventing translation of aberrant mRNAs. It seems to be involved in degradation of histone mRNA. The catalytic inactive RNA exosome core complex of 9 subunits (Exo-9) is proposed to play a pivotal role in the binding and presentation of RNA for ribonucleolysis, and to serve as a scaffold for the association with catalytic subunits and accessory proteins or complexes. EXOSC8 binds to ARE-containing RNAs.

Aliases: bA421P11.3 antibody, CBP interacting protein 3 antibody, CIP3 antibody, EAP2 antibody, EC 3.1.13 antibody, EXOS8_HUMAN antibody, EXOSC8 antibody, Exosome complex component RRP43 antibody, Exosome complex exonuclease RRP43 antibody, Exosome component 8 antibody, OIP-2 antibody, OIP2 antibody, Opa interacting protein 2 antibody, Opa-interacting protein 2 antibody, OTTHUMP00000042274 antibody, p9 antibody, Ribosomal RNA processing protein 43 antibody, Ribosomal RNA processing protein 43, S. cerevisiae, homolog of antibody, Ribosomal RNA-processing protein 43 antibody, RP11 421P11.3 antibody, RRP43 antibody, Rrp43p antibody

UniProt: Q96B26

Pathways: SARS-CoV-2 Protein Interactome